Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

SCOTUS hears oral argument in challenge to Chevron deference

The Checks and Balances Letter delivers news and information from Ballotpedia’s Administrative State Project, including pivotal actions at the federal and state levels related to the separation of powers, due process, and the rule of law.

Ballotpedia

Biden Administration Policy Jeopardizes The System That Gave Us Gene Editing

The White House just released a proposal that would allow federal agencies to rip up patent licensing agreements between universities -- which may receive federal research funds -- and private companies, including biotech firms.

International Business Times

Why people are taking bovine colostrum

Bovine colostrum supplements are taking over, but the evidence for some claims is lacking

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

DermaSensor announces AI skincare device that detects three common skin cancers

It's been FDA approved as of yesterday

Governor supports potential reclassification of marijuana as per FDA recommendation

In this informative response, Governor Haley discusses the potential reclassification of marijuana as well as the importance of allowing states to decide i...

Top News

Generic drugs in the US are too cheap to be sustainable, experts say

Non-brand-name drugs are one inexpensive part of the healthcare system but they’re driving some manufacturers out of business

The Guardian - US

"Faux-zempic" driving hospitalizations

Experts warn against the risks of illegitimately obtained Ozempic and Wegovy

Salon

Read news from The Economist, FT, and more,
with one subscription

FDA failing children with rare disease

The FDA is holding potential Sanfilippo syndrome therapies to an impossible and inhumane standard

Salon

Should you take melatonin gummies to fall asleep fast? Here's what a doctor thinks

Two sleep doctors answer everything you need to know about melatonin gummies, including the side effects, how long they last and how many you should take.

Tom’s Guide

What would a second Trump presidency look like for health care?

The former president is reviving campaign promises to undo Obamacare, an idea that fizzled during his first time in office. Based on his record, here's what else he might do in health policy.

WEKU

The Newly Unveiled HHS Rationale for Rescheduling Marijuana Underlines Drug Warriors' Dishonesty

The points about marijuana's risks and benefits that the department now concedes were clear long before last August.

Reason

A surgeon general report once cleared the air about smoking. Is it time for one on vaping?

Sixty years ago, the U.S. surgeon general released a report that settled a longstanding public debate about the dangers of cigarettes and led to huge changes in smoking in America

The Independent UK

When Your Heart Becomes a Snitch

Modern medical devices are lifesavers. But they’re vulnerable to hackers and compromise our privacy.

Reason

5 smartwatches to watch in 2024: Apple Watch 10, Samsung Galaxy Watch 7 and more

With no shortage of major releases on the docket, 2024 is likely to be an exciting year in the world of smartwatches.

Tom’s Guide

Get all your
news in one place.

100's of premium titles.
One news app.

Top News

FDA and NIDA recommend reclassifying marijuana to Schedule 3 substance

Find out about a review by the FDA supporting the reclassification of marijuana as a Schedule 3 substance due to its lower abuse potential and accepted med...

StockNews.com

Will These 3 Pharma Stocks Become Gainers in 2024?

The pharmaceutical sector is anticipated to prosper due to the strong demand for drugs and therapies and the adoption of advanced technologies. So, let’s analyze whether pharmaceutical stocks Kamada (KMDA), Neurocrine Biosciences (NBIX), and Novartis (NVS) are well positioned to capitalize on the industry’s growth prospects.

Top News

FDA deems ResMed's respiratory device recall as most severe

Learn about the recent recall of ResMed's respiratory devices by the US FDA, deemed as the most serious. Find out more about the implications and what acti...

Top News

FDA finds no evidence of suicidal thoughts from diabetes and obesity drugs

The FDA states that popular drugs for diabetes and obesity do not appear to be linked to suicidal thoughts but continues to investigate reports.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Drugs like Ozempic and Wegovy show no link with suicide, FDA says

Federal officials say a preliminary review finds no connection between suicidal thoughts and a new class of diabetes and obesity drugs

Tom’s Guide

Game-changing new wearable detects obstructive sleep apnea symptoms at home

People with obstructive sleep apnea symptoms can now get a diagnosis and treatment much sooner, thanks to a pioneering sleep apnea detection device.

WEKU

Blood tests can help diagnose Alzheimer's — if they're accurate enough. Not all are

A new generation of blood tests can help doctors diagnose Alzheimer's without a brain scan or spinal tap. But only a few perform as well as traditional tests.

Fortune

FDA allows imports of French syphilis drug alternate during US penicillin shortage

While as little as one injection of penicillin G benzathine can cure syphilis, the shortage prompted U.S. health officials to recommend giving some patients another antibiotic that requires of weeks of twice-daily pills.

The Independent UK

Boy George reveals he uses weight loss drug Mounjaro and had tummy tuck procedure

‘Trust me, anyone who was fat last year and is now skinny is on the wonder drug,’ singer writes in new memoir

Tom’s Guide

Withings BeamO debuts at CES 2024 — and it could revolutionize at-home health monitoring

The Withings Beamo ‘multiscope’ provides four useful health-monitoring tools in one convenient package.

Android Central

Withings BeamO is a DIY doctor's check-up wand synced to your phone

Announced at CES 2024, this all-in-one device will sync with your other Withings tech and give you a more in-depth look at your body than a smartwatch can offer.

1 … 121 122 123 124

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.